FUNDING PROGRAMME
HORIZON-HLTH-2023-DISEASE-03-01
DURATION
01.01.2024 – 31.12.2028
BUDGET
11.2 million euro
The EU PAL-COPD consortium brings together an outstanding team with excellent scientific, clinical and organisational expertise to deliver this study, interpret the findings appropriately and disseminate them to provide international impact on improving systems of care for patients with advanced COPD. The consortium builds upon a number of previous inter-national collaborations and national studies, by leading scientists in the fields of respiratory medicine, palliative care and health services research. The consortium reflects the expertise required to run a successful trial in what is often regarded as a challenging area. The consortium integrates a wide array of medical and social care disciplines, methodologies and domains, academic and civil society actors, research, practice, and policy-making expertise, at the forefront of palliative and end-of-life care for people with advanced COPD.
Goethe University was founded in 1914 as a unique ‘citizens’ university’, financed by wealthy citizens in Frankfurt, Germany. Named in 1932 after one of the city’s most famous natives, Johann Wolfgang von Goethe, today the university has over 48,000 students. The University Hospital Frankfurt (UHF) consists of 32 specialist clinics and clinical institutes as well as more than 20 research institutes and, together with the Goethe University Frankfurt, ensures the link be-tween teaching, research and health care. The Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy (KAIS), as the central facility of the UHF (1,500 beds), supplies all operative and diagnostic areas and provides over 30,000 anaesthetic procedures every year. KAIS is running several anaesthetic-operative intensive care units (over 50 beds). In addition, we regularly care for patients of other specialist intensive care and monitoring wards. Our pain clinic looks after both out- and inpatients with chronic and acute postoperative pain.
Role in EU PAL-COPD
The information you provide will only be used for newsletter campaigns by EU PAL-COPD. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s terms of use. You can unsubscribe at any time by clicking the link in the footer of our emails. Read our privacy policy to learn how your data is used.
EU PAL-COPD is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them [grant number 101136621]. This project is also supported by the UK Research and Innovation (UKRI) [grant numbers 10109731 and 10109782], the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund [grant number 2020-2.1.1-ED-2023-00260], and the Swiss State Secretariat for Education, Research and Innovation (SERI).
© 2024 accelopment Schweiz AG · info@accelopment.com · ISO 9001 certified · Read our Privacy Policy and Cookie Policy
